{"id":"https://openalex.org/W2055837944","doi":"https://doi.org/10.1002/cncr.24127","title":"Initiation of epoetin\u2010\u03b1 therapy at a starting dose of 120,000 units once every 3 weeks in patients with cancer receiving chemotherapy","display_name":"Initiation of epoetin\u2010\u03b1 therapy at a starting dose of 120,000 units once every 3 weeks in patients with cancer receiving chemotherapy","publication_year":2009,"publication_date":"2009-01-23","ids":{"openalex":"https://openalex.org/W2055837944","doi":"https://doi.org/10.1002/cncr.24127","mag":"2055837944","pmid":"https://pubmed.ncbi.nlm.nih.gov/19170225"},"language":"en","primary_location":{"id":"doi:10.1002/cncr.24127","doi":"https://doi.org/10.1002/cncr.24127","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.24127","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.24127","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.24127","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080006341","display_name":"John A. Glaspy","orcid":"https://orcid.org/0000-0002-1800-9076","observed_orcids":["https://orcid.org/0000-0002-1800-9076"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John A. Glaspy","raw_affiliation_strings":["Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, California 90095-6956, USA. jglaspy@mednet.ucla.edu","Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, California 90095-6956, USA. jglaspy@mednet.ucla.edu","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, California","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034876741","display_name":"Veena Charu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Veena Charu","raw_affiliation_strings":["Private Practice, Pacific Cancer Medical Center, Anaheim, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Private Practice, Pacific Cancer Medical Center, Anaheim, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052545307","display_name":"Donghan Luo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Donghan Luo","raw_affiliation_strings":["Ortho Biotech Clinical Affairs, LLC, Bridgewater, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ortho Biotech Clinical Affairs, LLC, Bridgewater, New Jersey","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059232093","display_name":"Victor M. Moyo","orcid":"https://orcid.org/0000-0001-8470-5347","observed_orcids":["https://orcid.org/0000-0001-8470-5347"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victor Moyo","raw_affiliation_strings":["Ortho Biotech Clinical Affairs, LLC, Bridgewater, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ortho Biotech Clinical Affairs, LLC, Bridgewater, New Jersey","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033661505","display_name":"Marc Kamin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marc Kamin","raw_affiliation_strings":["Ortho Biotech Clinical Affairs, LLC, Bridgewater, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ortho Biotech Clinical Affairs, LLC, Bridgewater, New Jersey","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033199189","display_name":"Francois E. Wilhelm","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francois E. Wilhelm","raw_affiliation_strings":["Ortho Biotech Clinical Affairs, LLC, Bridgewater, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ortho Biotech Clinical Affairs, LLC, Bridgewater, New Jersey","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5080006341"],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":1.0962,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.80360869,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"115","issue":"5","first_page":"1121","last_page":"1131"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epoetin-alfa","display_name":"epoetin alfa","score":0.9639999866485596},{"id":"https://openalex.org/keywords/chemotherapy-induced-anemia","display_name":"chemotherapy-induced anemia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cancer-patients","display_name":"cancer patients","score":0.671999990940094},{"id":"https://openalex.org/keywords/hemoglobin-maintenance","display_name":"hemoglobin maintenance","score":0.7179999947547913},{"id":"https://openalex.org/keywords/blood-transfusion","display_name":"blood transfusion","score":0.7310000061988831},{"id":"https://openalex.org/keywords/anemia-treatment","display_name":"anemia treatment","score":0.5249999761581421}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9552642703056335},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.7151654958724976},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.693185031414032},{"id":"https://openalex.org/C2776164570","wikidata":"https://www.wikidata.org/wiki/Q5383794","display_name":"Epoetin alfa","level":3,"score":0.46504297852516174},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38903436064720154},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3641422688961029}],"mesh":[{"descriptor_ui":"D000068817","descriptor_name":"Epoetin Alfa","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001803","descriptor_name":"Blood Transfusion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006454","descriptor_name":"Hemoglobins","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/cncr.24127","doi":"https://doi.org/10.1002/cncr.24127","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.24127","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.24127","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:19170225","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19170225","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/cncr.24127","doi":"https://doi.org/10.1002/cncr.24127","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cncr.24127","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.24127","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2055837944.pdf","grobid_xml":"https://content.openalex.org/works/W2055837944.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W1989722114","https://openalex.org/W2044993646","https://openalex.org/W2052549424","https://openalex.org/W2063931484","https://openalex.org/W2064154338","https://openalex.org/W2112833469","https://openalex.org/W2115716425","https://openalex.org/W2142572175","https://openalex.org/W2149721168","https://openalex.org/W2150023617","https://openalex.org/W2150616882","https://openalex.org/W2163830215","https://openalex.org/W2167467743"],"related_works":["https://openalex.org/W2058251329","https://openalex.org/W2247377728","https://openalex.org/W2595770802","https://openalex.org/W2970134979","https://openalex.org/W2540911414","https://openalex.org/W2014883501","https://openalex.org/W2978019719","https://openalex.org/W2108990577","https://openalex.org/W2567405999","https://openalex.org/W2115716425"],"abstract_inverted_index":{"BACKGROUND:":[0],"Epoetin-alpha":[1],"initiated":[2,94],"once":[3,27,230],"weekly,":[4],"followed":[5],"by":[6,134],"once-every-3-weeks":[7],"maintenance,":[8],"was":[9,93,99,126],"effective":[10],"and":[11,36,149,157,170,211,219,224,235],"well":[12],"tolerated":[13],"for":[14,31,192,208],"chemotherapy-induced":[15,32,245],"anemia.":[16,246],"This":[17],"study":[18,204],"evaluated":[19],"a":[20],"starting":[21],"dose":[22],"of":[23,77,102,118,151,201,213],"epoetin-alpha":[24,55,64,92,161,193],"120,000":[25],"U":[26],"every":[28,231],"3":[29,232],"weeks":[30],"anemia":[33],"using":[34],"early":[35,51,177],"late":[37],"initiation":[38],"regimens.":[39],"METHODS:":[40],"Patients":[41],"with":[42,53,63,79,188,227,244],"baseline":[43,80],"hemoglobin":[44,66,81,103,119,133,237],"11.0-12.0":[45],"g/dL":[46,70,83,241],"were":[47,87,144,163,172,186,206],"randomly":[48],"assigned":[49],"to":[50,60,68,203],"intervention":[52,62,178,226],"immediate":[54],"(n":[56,71,84],"=":[57,72,85],"68)":[58],"or":[59],"standard":[61,225],"when":[65],"decreased":[67],"<11":[69,82],"68).":[73],"A":[74],"third":[75],"group":[76],"patients":[78,152,214,243],"50)":[86],"enrolled":[88],"but":[89],"not":[90],"randomized;":[91],"immediately.":[95],"The":[96,115],"primary":[97],"endpoint":[98],"mean":[100,116],"proportion":[101,117],"values":[104,120],"within":[105,239],"the":[106,140,154,176,189,216],"target":[107],"range":[108,122],"(11.0-13.0":[109],"g/dL)":[110],"among":[111],"randomized":[112,130],"patients.":[113],"RESULTS:":[114],"in":[121,128,146,153,175,215,242],"through":[123],"week":[124,135],"16":[125],"60%":[127],"each":[129],"group.":[131,179],"Mean":[132,160],"showed":[136],"similar":[137,164],"increases":[138],"over":[139],"study.":[141],"Blood":[142],"transfusions":[143],"administered":[145,229],"9%,":[147,209],"8%,":[148],"24%":[150],"early,":[155,217],"standard,":[156,218],"nonrandomized":[158,220],"groups.":[159,167,221],"doses":[162],"between":[165],"treatment":[166],"Dose":[168],"reductions":[169],"withholds":[171],"more":[173],"common":[174],"Adverse":[180],"events":[181,199],"(eg,":[182],"diarrhea,":[183],"fatigue,":[184],"nausea)":[185],"consistent":[187],"safety":[190],"profile":[191],".":[194],"Clinically":[195],"relevant":[196],"thrombotic":[197],"vascular":[198],"(regardless":[200],"relationship":[202],"treatment)":[205],"reported":[207],"12%,":[210],"12%":[212],"CONCLUSIONS:":[222],"Early":[223],"epoetin-alpha,":[228],"weeks,":[233],"increased":[234],"maintained":[236],"levels":[238],"11.0-13.0":[240]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}